OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC Logo

OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC

OCTHF | IL

Overview

Corporate Details

ISIN(s):
GB00BMVMRB86
LEI:
2138005SRWT4998BCE35
Country:
United Kingdom
Address:
PRAMA HOUSE, 267 BANBURY ROAD, OX2 7HT OXFORD
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

As of May 2, 2025, Oxford Cannabinoid Technologies Holdings PLC has entered administration and ceased trading. Prior to this, the company operated as a clinical-stage biopharmaceutical firm focused on the research, development, and commercialization of prescription cannabinoid-based medicines. Its primary mission was to create non-addictive therapies for the pain market as alternatives to opioids. The company's research and development efforts targeted the endocannabinoid system (ECS), utilizing a portfolio of compounds that included proprietary derivatives, in-licensed assets, and new chemical entities.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2024-06-06 08:00
Delisting Announcement
Cancellation of Listing
English 10.0 KB
2024-05-31 08:00
Delisting Announcement
Updated Shareholder Engagement
English 10.6 KB
2024-05-17 17:30
Delisting Announcement
Updated Shareholder Information
English 22.6 KB
2024-05-08 08:00
Delisting Announcement
Intended Cancellation of Listing
English 32.1 KB
2024-04-11 12:26
Report Publication Announcement
Appointment of Phase I Clinical Trial CRO
English 17.3 KB
2024-04-03 09:00
Regulatory News Service
OCT Company Update with Doceo
English 7.4 KB
2024-03-26 11:56
Report Publication Announcement
Oxford Cannabinoid Technologies video with Doceo
English 6.9 KB
2024-03-18 08:00
Regulatory News Service
Appointment of Hybridan as Adviser
English 14.2 KB
2024-02-29 08:02
Board/Management Information
Directorate Appointment
English 15.3 KB
2024-02-29 08:01
Board/Management Information
Directorate Changes
English 16.2 KB
2024-02-29 08:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 11.8 KB
2024-02-28 18:35
Major Shareholding Notification
TR-1: NOTIFICATION OF MAJOR HOLDINGS
English 65.2 KB
2024-02-28 18:34
Major Shareholding Notification
TR-1: NOTIFICATION OF MAJOR HOLDINGS
English 71.7 KB
2024-02-28 18:34
Major Shareholding Notification
TR-1: NOTIFICATION OF MAJOR HOLDINGS
English 65.4 KB
2024-02-26 14:07
Director's Dealing
Directors’ Dealings
English 40.8 KB

Automate Your Workflow. Get a real-time feed of all OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
RYVU Therapeutics S.A. Logo
Clinical-stage drug discovery company developing novel small molecule therapies for oncology.
Poland RVU
Saniona Logo
Biopharma developing medicines for epilepsy and neurological disorders using ion channel research.
Denmark SANION
SAREUM HOLDINGS PLC Logo
Clinical-stage developer of kinase inhibitors for autoimmune disease & cancer.
United Kingdom SAR
SCANCELL HOLDINGS PLC Logo
Developing therapeutic vaccines and antibodies for cancer and infectious diseases.
United Kingdom SCLP
Scandion Oncology A/S Logo
A liquidated biotech that developed oral drugs to overcome cancer treatment resistance.
Denmark SCOL
SCIENCE GROUP PLC Logo
International science & tech consultancy providing advisory, R&D, and product development.
United Kingdom SAG
Selvita S.A. Logo
Preclinical CRO offering integrated drug discovery and development services for life sciences.
Poland SLV
Sensorion Logo
Clinical-stage biotech developing novel therapies for hearing loss, vertigo, and tinnitus.
France ALSEN
Simris Group AB Logo
Develops novel cyanobacteria-based payloads for Antibody-Drug Conjugates to treat cancer.
Sweden SIMRIS
SKINBIOTHERAPEUTICS PLC Logo
A life science company developing microbiome-based skin health products and supplements.
United Kingdom SBTX